Litcius/Paper detail

Encephalopathy and Encephalitis Associated with Cerebrospinal Fluid Cytokine Alterations and Coronavirus Disease, Atlanta, Georgia, USA, 2020

Karima Benameur, Ankita Agarwal, Sara C. Auld, Matthew P. Butters, Andrew S Webster, Tuğba Öztürk, J. Christina Howell, Leda Bassit, Alvaro Velasquez, Raymond F. Schinazi, Mark E. Mullins, William T. Hu

2020Emerging infectious diseases179 citationsDOIOpen Access PDF

Abstract

There are few detailed investigations of neurologic complications in severe acute respiratory syndrome coronavirus 2 infection. We describe 3 patients with laboratory-confirmed coronavirus disease who had encephalopathy and encephalitis develop. Neuroimaging showed nonenhancing unilateral, bilateral, and midline changes not readily attributable to vascular causes. All 3 patients had increased cerebrospinal fluid (CSF) levels of anti-S1 IgM. One patient who died also had increased levels of anti-envelope protein IgM. CSF analysis also showed markedly increased levels of interleukin (IL)-6, IL-8, and IL-10, but severe acute respiratory syndrome coronavirus 2 was not identified in any CSF sample. These changes provide evidence of CSF periinfectious/postinfectious inflammatory changes during coronavirus disease with neurologic complications.

Topics & Concepts

AtlantaVirologyCoronavirusEncephalitisCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Medicine2019-20 coronavirus outbreakCerebrospinal fluidViral encephalitisDiseaseVirusPathologyInfectious disease (medical specialty)OutbreakMetropolitan areaLong-Term Effects of COVID-19Infectious Encephalopathies and EncephalitisMultiple Sclerosis Research Studies
Encephalopathy and Encephalitis Associated with Cerebrospinal Fluid Cytokine Alterations and Coronavirus Disease, Atlanta, Georgia, USA, 2020 | Litcius